查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1597811

豬疫苗市場：按產品類型、目標疾病分類 - 2025-2030 年全球預測

Swine Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Type (Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease), Target Disease - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年豬疫苗市值為14.7億美元，預計2024年將達15.8億美元，複合年成長率為7.54%，預計2030年將達24.5億美元。

豬疫苗市場是指用於預防和控制豬傳染病的疫苗的生產、分銷和應用，主要是為了維持豬的健康、確保生物安全並支持永續的豬肉生產。這些疫苗用於預防多種疾病，包括豬繁殖與呼吸綜合症（PRRS）、豬流感和黴漿菌。最終使用者主要是獸醫醫院、養豬場和畜牧設施。關鍵的成長要素包括豬病發病率的增加、全球豬肉產品需求的增加以及對動物健康和福祉的認知不斷提高。重組 DNA 技術等技術進步和次單位疫苗疫苗和 DNA 疫苗等新型疫苗的開拓進一步塑造了市場動態，這帶來了潛在的商機，特別是對於投資於研發和戰略夥伴關係的公司。然而，挑戰包括嚴格的法律規範、疫苗開發和生產的高成本以及飼料和其他牲畜必需品的價格波動，這些可能會阻礙市場擴張。此外，它們還面臨疫苗功效變化和新病原體出現的限制。因此，創新領域包括開發具有更廣泛頻譜的疫苗、提高疫苗穩定性和儲存條件，以及整合用於疾病監測和疫苗管理的數位工具。為了利用這些機會，公司應優先投資於尖端研究、全球分銷網路以及對監管環境的透徹了解。快速變化的市場條件和競爭需要靈活的策略來適應新的科學發現和消費者需求，並確保動物健康、永續性和經濟可行性之間的平衡。

主要市場統計
基準年[2023] 14.7億美元
預計年份 [2024] 15.8億美元
預測年份 [2030] 24.5億美元
複合年成長率（%） 7.54%

市場動態：揭示快速發展的豬隻疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變豬隻疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 豬肉消費增加
    • 人們對牲畜健康的認知不斷增強
  • 市場限制因素
    • 疫苗供應有限
  • 市場機會
    • 新疫苗開發的研究與開發
  • 市場挑戰
    • 獸醫短缺

波特的五力戰略工具駕馭豬疫苗市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解豬隻疫苗市場的外部影響

外部宏觀環境因素對豬隻疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解豬隻疫苗市場競爭狀況

對豬疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣豬疫苗市場供應商績效評估

FPNV定位矩陣是評估豬隻疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了豬疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對豬疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 豬肉消費量增加
      • 人們對牲畜健康的認知不斷增強
    • 抑制因素
      • 疫苗供應有限
    • 機會
      • 新疫苗開發的研究與開發
    • 任務
      • 獸醫短缺
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章豬疫苗市場：依產品

  • 減毒活病毒疫苗
  • DNA疫苗
  • 去活化疫苗
  • 重組疫苗
  • 次單位疫苗

第7章豬疫苗市場：依類型

  • 胸膜肺炎放線桿菌
  • 豬瘟
  • 手足口病
  • M·豹子
  • 佩多夫
  • 豬環狀病毒2型
  • 豬細小病毒
  • 抗逆轉錄病毒藥物
  • 偽狂犬病
  • 豬流感

第8章豬疫苗市場目標疾病

  • 關節炎
  • 博德特菌性鼻炎
  • 腹瀉
  • 手足口病
  • 豬環狀病毒相關疾病
  • 豬繁殖與呼吸綜合症
  • 偽狂犬病
  • 豬流感

第9章美洲豬疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太豬疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲豬疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bayer AG
  • Ceva Sante Animale
  • China, Jinyu Bio-technology Co., Ltd.
  • Covetrus Inc.
  • Dechra Pharmaceuticals plc
  • Elanco Animal Health Incorporated
  • HIPRA
  • Huvepharma EOOD
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd
  • Merck & Co., Inc.
  • Phibro Animal Health
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-3A2E844FD486

The Swine Vaccines Market was valued at USD 1.47 billion in 2023, expected to reach USD 1.58 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 2.45 billion by 2030.

The swine vaccines market is defined by the production, distribution, and application of vaccines that aim to prevent and control infectious diseases in pigs, primarily driven by the necessity to maintain swine health, ensure biosecurity, and support sustainable pork production. The application of these vaccines spans across various diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Mycoplasma, to name a few. End-users predominantly encompass veterinary clinics, swine farms, and animal husbandry facilities. Key growth factors include the increasing incidence of swine diseases, rising demand for pork products globally, and heightened awareness regarding animal health and welfare. Market dynamics are further shaped by technological advancements such as recombinant DNA technology and the development of newer vaccine types such as subunit and DNA vaccines, presenting potential opportunities particularly for companies investing in R&D and strategic partnerships. However, challenges include stringent regulatory frameworks, high costs associated with vaccine development and production, and the fluctuating prices of feed and other livestock essentials, which can hinder market expansion. Moreover, the industry faces limitations due to varying vaccine efficacy and the emergence of novel pathogens. Consequently, areas ripe for innovation include the development of vaccines with broader spectrums of action, enhancing vaccine stability and storage conditions, and the integration of digital tools for disease monitoring and vaccine management. To capitalize on these opportunities, businesses should prioritize investment in cutting-edge research, global distribution networks, and a thorough understanding of the regulatory landscape. The swine vaccines market is characterized by rapid advancements and a competitive landscape, demanding agile strategies to adapt to new scientific findings and consumer needs, ensuring a robust balance between animal health, sustainability, and economic viability.

KEY MARKET STATISTICS
Base Year [2023] USD 1.47 billion
Estimated Year [2024] USD 1.58 billion
Forecast Year [2030] USD 2.45 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Swine Vaccines Market

The Swine Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising consumption of pork meat
    • Growing awareness related to livestock health
  • Market Restraints
    • Limited availability of vaccine
  • Market Opportunities
    • R&D for novel vaccine developments
  • Market Challenges
    • Dearth of veterinary practitioners

Porter's Five Forces: A Strategic Tool for Navigating the Swine Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Swine Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Swine Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Swine Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Swine Vaccines Market

A detailed market share analysis in the Swine Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Swine Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Swine Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Swine Vaccines Market

A strategic analysis of the Swine Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Swine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Ceva Sante Animale, China, Jinyu Bio-technology Co., Ltd., Covetrus Inc., Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, HIPRA, Huvepharma EOOD, IDEXX Laboratories, Inc., Indian Immunologicals Ltd, Merck & Co., Inc., Phibro Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Swine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
  • Based on Type, market is studied across Actinobacillus Pleuropneumoniae, Classical Swine Fever, Foot & Mouth Disease, M. Hyo, PEDV, Porcine Circovirus Type 2, Porcine Parvovirus, PRRS, Pseudorabies, and Swine Influenza.
  • Based on Target Disease, market is studied across Arthritis, Bordetella Rhinitis, Diarrhea, Foot & Mouth Disease, Porcine Circovirus Associated Disease, Porcine Reproductive & Respiratory Syndrome, Pseudorabies, and Swine Influenza.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising consumption of pork meat
      • 5.1.1.2. Growing awareness related to livestock health
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of vaccine
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D for novel vaccine developments
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of veterinary practitioners
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Swine Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Swine Vaccines Market, by Type

  • 7.1. Introduction
  • 7.2. Actinobacillus Pleuropneumoniae
  • 7.3. Classical Swine Fever
  • 7.4. Foot & Mouth Disease
  • 7.5. M. Hyo
  • 7.6. PEDV
  • 7.7. Porcine Circovirus Type 2
  • 7.8. Porcine Parvovirus
  • 7.9. PRRS
  • 7.10. Pseudorabies
  • 7.11. Swine Influenza

8. Swine Vaccines Market, by Target Disease

  • 8.1. Introduction
  • 8.2. Arthritis
  • 8.3. Bordetella Rhinitis
  • 8.4. Diarrhea
  • 8.5. Foot & Mouth Disease
  • 8.6. Porcine Circovirus Associated Disease
  • 8.7. Porcine Reproductive & Respiratory Syndrome
  • 8.8. Pseudorabies
  • 8.9. Swine Influenza

9. Americas Swine Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Swine Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Swine Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer AG
  • 2. Ceva Sante Animale
  • 3. China, Jinyu Bio-technology Co., Ltd.
  • 4. Covetrus Inc.
  • 5. Dechra Pharmaceuticals plc
  • 6. Elanco Animal Health Incorporated
  • 7. HIPRA
  • 8. Huvepharma EOOD
  • 9. IDEXX Laboratories, Inc.
  • 10. Indian Immunologicals Ltd
  • 11. Merck & Co., Inc.
  • 12. Phibro Animal Health
  • 13. Vetoquinol S.A.
  • 14. Virbac S.A.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. SWINE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SWINE VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY ACTINOBACILLUS PLEUROPNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY M. HYO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY PEDV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS TYPE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY PRRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY BORDETELLA RHINITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 84. TAIWAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 87. THAILAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. THAILAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. VIETNAM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. VIETNAM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. VIETNAM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 97. DENMARK SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. DENMARK SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. DENMARK SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 100. EGYPT SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EGYPT SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EGYPT SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 103. FINLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. FINLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. FINLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. FRANCE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. FRANCE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. FRANCE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 109. GERMANY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. GERMANY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. GERMANY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 112. ISRAEL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. ISRAEL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ISRAEL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 115. ITALY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. ITALY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. ITALY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 121. NIGERIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. NIGERIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. NIGERIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 124. NORWAY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. NORWAY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. NORWAY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. POLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. POLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. POLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 130. QATAR SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. QATAR SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. QATAR SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 133. RUSSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. RUSSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. RUSSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 136. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 142. SPAIN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SPAIN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. SPAIN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 145. SWEDEN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SWEDEN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SWEDEN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 148. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. TURKEY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. TURKEY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TURKEY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
  • TABLE 160. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 161. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023